Robert A Hauser

22PUBLICATIONS
54CO-AUTHORS
Liquid biopsiesMolecular targetsDental therapeutics, pharmacology and toxicologyOrthodontics and dentofacial orthopaedicsMortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 07, 2026
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.

|Feb 20, 2026
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.

M H Werner, A McGarry, C Meyer

|Feb 04, 2026
DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real-World Early Experience Program.

Laxman Bahroo, Aaron Ellenbogen, Robert A Hauser

|Dec 13, 2025
LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's Disease.

Anthony E Lang, Robert A Hauser, Lorraine V Kalia

|Mar 26, 2025
Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA.

Aaron Ellenbogen, Robert A Hauser, Atul T Patel

|Mar 24, 2025
Burden of tremor in Parkinson's disease: A survey study.

Robert A Hauser, Tara Crowder Skarpaas, Andréa Merriam

Pageof 4

Frequent Collaborators

2 joint publications

Anette Schrag

1 joint publications

M H Werner

1 joint publications

A McGarry

1 joint publications

K Kieburtz